Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15523)
All Articles published online
|
Publishing Process of This Article
|
Mar 22, 2016 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lai CY, Scarr E, Udawela M, Everall I, Chen WJ, Dean B. Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. World J Psychiatr 2016; 6(1): 102-117 [PMID: 27014601 DOI: 10.5498/wjp.v6.i1.102] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v6/i1/102.htm |
| Number | Citing Articles |
| 1 |
Michael D.E. Sewell, Lorena Jiménez-Sánchez, Xueyi Shen, Amelia J. Edmondson-Stait, Claire Green, Mark J. Adams, Olivia M. Rifai, Andrew M. McIntosh, Donald M. Lyall, Heather C. Whalley, Stephen M. Lawrie. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank. Brain, Behavior, and Immunity 2021; 97: 32 doi: 10.1016/j.bbi.2021.06.002
|
| 2 |
|
| 3 |
C.M. Loureiro, R. Shuhama, H.A. Fachim, P.R. Menezes, C.M. Del-Ben, P. Louzada-Junior. Low plasma concentrations of N-methyl-d-aspartate receptor subunits as a possible biomarker for psychosis. Schizophrenia Research 2018; 202: 55 doi: 10.1016/j.schres.2018.06.037
|
| 4 |
Xinzhe Du, Jinzhi Lv, Jianping Feng, Xinrong Li, Yao Gao, Xiao Wang, Wentao Zhao, Zhiyong Ren, Ruifang Zhang, Xiaohua Cao, Sha Liu, Yong Xu. Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia. BMC Psychiatry 2023; 23(1) doi: 10.1186/s12888-023-05052-9
|
| 5 |
Rudolf Engelke, Sami Ouanes, Suhaila Ghuloum, Rifka Chamali, Nancy Kiwan, Hina Sarwath, Frank Schmidt, Karsten Suhre, Hassen Al-Amin. Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.809071
|
| 6 |
Lucas B. Galdino, Thiago Fernandes, Kerstin E. Schmidt, Natanael A. Santos. Altered brain connectivity during visual stimulation in schizophrenia. Experimental Brain Research 2022; 240(12): 3327 doi: 10.1007/s00221-022-06495-4
|
| 7 |
Jemmyson Romário de Jesus, Tatianny de Araujo Andrade, Eduardo Costa de Figueiredo. Advances In Clinical Chemistry. Advances in Clinical Chemistry 2023; 116: 183 doi: 10.1016/bs.acc.2023.05.005
|
| 8 |
Charalampos T Kazakos, Vasilios Karageorgiou. Retinal Changes in Schizophrenia: A Systematic Review and Meta-analysis Based on Individual Participant Data. Schizophrenia Bulletin 2019; doi: 10.1093/schbul/sbz106
|
| 9 |
Yousra Zeinelabdeen, Tasneem Abaza, Montaser Bellah Yasser, Noha M. Elemam, Rana A. Youness. MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions. Non-coding RNA Research 2024; 9(2): 447 doi: 10.1016/j.ncrna.2024.01.011
|
| 10 |
Jiajun Yin, Yana Lu, Shui Yu, Zhanzhan Dai, Fuquan Zhang, Jianmin Yuan. Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment. Hereditas 2020; 157(1) doi: 10.1186/s41065-020-00158-6
|
| 11 |
Margareth Borges Coutinho Gallo. Seeking Molecular Biomarkers for Schizophrenia Using ROC Analysis. 2024; : 13 doi: 10.1007/978-3-031-59028-3_2
|
| 12 |
Junfang Chen, Emanuel Schwarz. The role of blood-based biomarkers in advancing personalized therapy of schizophrenia. Expert Review of Precision Medicine and Drug Development 2017; 2(6): 363 doi: 10.1080/23808993.2017.1400906
|
| 13 |
A. V. Yakimets, S. A. Zozulya, I. V. Oleichik, T. P. Klyushnik. Dynamics of clinical and biological indices of the asthenic symptom-complex during immunotropic therapy of patients with schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2018; 118(3): 70 doi: 10.17116/jnevro20181183170-76
|
| 14 |
Margareth Borges Coutinho Gallo. Seeking Molecular Biomarkers for Schizophrenia Using ROC Analysis. 2024; : 37 doi: 10.1007/978-3-031-59028-3_3
|
| 15 |
Kosuke Kajitani, Kazuyuki Yanagimoto, Yusaku Nakabeppu. Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation. Psychopharmacology 2017; 234(19): 2919 doi: 10.1007/s00213-017-4683-9
|
| 16 |
Cynthia H. Lee, Duncan Sinclair, Maryanne O'Donnell, Cherrie Galletly, Dennis Liu, Cynthia Shannon Weickert, Thomas W. Weickert. Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. Schizophrenia Research 2019; 213: 87 doi: 10.1016/j.schres.2019.06.026
|
| 17 |
Boris Chaumette, Oussama Kebir, Juliette Pouch, Bertrand Ducos, Fekrije Selimi, Raphael Gaillard, Marie-Odile Krebs. Longitudinal Analyses of Blood Transcriptome During Conversion to Psychosis. Schizophrenia Bulletin 2019; 45(1): 247 doi: 10.1093/schbul/sby009
|
| 18 |
Jingyu Liu, Jiayu Chen, Nora Perrone-Bizzozero, Vince D. Calhoun. A Perspective of the Cross-Tissue Interplay of Genetics, Epigenetics, and Transcriptomics, and Their Relation to Brain Based Phenotypes in Schizophrenia. Frontiers in Genetics 2018; 9 doi: 10.3389/fgene.2018.00343
|
| 19 |
William R. Reay, Dylan J. Kiltschewskij, Michael P. Geaghan, Joshua R. Atkins, Vaughan J. Carr, Melissa J. Green, Murray J. Cairns. Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders. Science Advances 2022; 8(14) doi: 10.1126/sciadv.abj8969
|
| 20 |
Zhaoming Cao, Yage Du, Guangyi Xu, He Zhu, Yinchao Ma, Ziyuan Wang, Shaoying Wang, Yanhui Lu. From Diabetes to Dementia: Identifying Key Genes in the Progression of Cognitive Impairment. Brain Sciences 2024; 14(10): 1035 doi: 10.3390/brainsci14101035
|
| 21 |
E.S. Ershova, E.M. Jestkova, I.V. Chestkov, L.N. Porokhovnik, V.L. Izevskaya, S.I. Kutsev, N.N. Veiko, G. Shmarina, O. Dolgikh, S.V. Kostyuk. Quantification of cell-free DNA in blood plasma and DNA damage degree in lymphocytes to evaluate dysregulation of apoptosis in schizophrenia patients. Journal of Psychiatric Research 2017; 87: 15 doi: 10.1016/j.jpsychires.2016.12.006
|
| 22 |
Hani Sabaie, Madiheh Mazaheri Moghaddam, Marziyeh Mazaheri Moghaddam, Noora Karim Ahangar, Mohammad Reza Asadi, Bashdar Mahmud Hussen, Mohammad Taheri, Maryam Rezazadeh. Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-03993-3
|
| 23 |
Jiahui Ma, Lailai Yan, Tongjun Guo, Siyu Yang, Dawei Ni, Yaqiong Liu, Jingyu Wang. A pilot study of biomarkers of oxidative stress in serum and schizophrenia. Psychiatry Research 2020; 284: 112757 doi: 10.1016/j.psychres.2020.112757
|
| 24 |
James R. Mansfield, Paul C. Guest, Jared Burks. Proteomic Methods in Neuropsychiatric Research. Advances in Experimental Medicine and Biology 2017; 974: 327 doi: 10.1007/978-3-319-52479-5_32
|
| 25 |
H. Alex Ding. Emerging Concepts of Specific Components of the Immune System in Schizophrenia. American Journal of Psychiatry Residents' Journal 2018; 13(10): 2 doi: 10.1176/appi.ajp-rj.2018.131001
|
| 26 |
Eunkyoung Kim, Jinyang Li, Mijeong Kang, Deanna L. Kelly, Shuo Chen, Alessandra Napolitano, Lucia Panzella, Xiaowen Shi, Kun Yan, Si Wu, Jana Shen, William E. Bentley, Gregory F. Payne. Redox Is a Global Biodevice Information Processing Modality. Proceedings of the IEEE 2019; 107(7): 1402 doi: 10.1109/JPROC.2019.2908582
|
| 27 |
S Liu, F Zhang, Y Y Shugart, L Yang, X Li, Z Liu, N Sun, C Yang, X Guo, J Shi, L Wang, L Cheng, K Zhang, T Yang, Y Xu. The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring. Translational Psychiatry 2017; 7(1): e998 doi: 10.1038/tp.2016.268
|
| 28 |
Margareth Borges Coutinho Gallo. Seeking Molecular Biomarkers for Schizophrenia Using ROC Analysis. 2024; : 135 doi: 10.1007/978-3-031-59028-3_8
|
| 29 |
Noriaki Yahata, Kiyoto Kasai, Mitsuo Kawato. Computational neuroscience approach to biomarkers and treatments for mental disorders. Psychiatry and Clinical Neurosciences 2017; 71(4): 215 doi: 10.1111/pcn.12502
|
| 30 |
Xingbing Huang, Xiong Huang, Yanling Zhou, Hongbo He, Fang Mei, Bin Sun, Jair C. Soares, Xiang Yang Zhang. Association of serum BDNF levels with psychotic symptom in chronic patients with treatment-resistant depression in a Chinese Han population. Psychiatry Research 2017; 257: 279 doi: 10.1016/j.psychres.2017.07.076
|
| 31 |
Elizaveta S. Ershova, Oksana N. Agafonova, Natalia V. Zakharova, Lidia V. Bravve, Elizaveta M. Jestkova, Vera E. Golimbet, Tatiana V. Lezheiko, Anna Y. Morozova, Andrey V. Martynov, Roman V. Veiko, Pavel E. Umriukhin, Georgiy P. Kostyuk, Sergey I. Kutsev, Natalia N. Veiko, Svetlana V. Kostyuk. Copy Number Variation of Satellite III (1q12) in Patients With Schizophrenia. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.01132
|
| 32 |
Mohammad Reza Safari, Alireza Komaki, Shahram Arsang-Jang, Mohammad Taheri, Soudeh Ghafouri-Fard. Expression Pattern of Long Non-coding RNAs in Schizophrenic Patients. Cellular and Molecular Neurobiology 2019; 39(2): 211 doi: 10.1007/s10571-018-0640-3
|
| 33 |
Xiaowei Tang, Chao Zhou, Ju Gao, Weiwei Duan, Miao Yu, Wenhuan Xiao, Xiaobin Zhang, Hui Dong, Xiang Wang, Xiangrong Zhang. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction. BMC Psychiatry 2019; 19(1) doi: 10.1186/s12888-019-2231-3
|
| 34 |
Michal Ordak, Malgorzata Libman-Sokolowska, Tadeusz Nasierowski, Bogna Badyra, Leszek Kaczmarek, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Matrix metalloproteinase-3 serum levels in schizophrenic patients. International Journal of Psychiatry in Clinical Practice 2023; 27(1): 1 doi: 10.1080/13651501.2022.2057332
|
| 35 |
Clément Dondé, Marine Mondino, Jérôme Brunelin, Frédéric Haesebaert. Sensory-targeted cognitive training for schizophrenia. Expert Review of Neurotherapeutics 2019; 19(3): 211 doi: 10.1080/14737175.2019.1581609
|
| 36 |
Eriko Tani, Tohru Ohnuma, Hitoki Hirose, Ken Nakayama, Wanyi Mao, Mariko Nakadaira, Narihiro Orimo, Hiroki Yamashita, Yuto Takebayashi, Yasue Miki, Narimasa Katsuta, Shohei Nishimon, Toshio Hasegawa, Etsuko Komiyama, Yasushi Suga, Shigaku Ikeda, Heii Arai. Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia. International Journal of Methods in Psychiatric Research 2019; 28(1) doi: 10.1002/mpr.1769
|
| 37 |
Zhijun Li, Xinwei Li, Mengdi Jin, Yang Liu, Yang He, Ningning Jia, Xingyao Cui, Yane Liu, Guoyan Hu, Qiong Yu. Identification of potential blood biomarkers for early diagnosis of schizophrenia through RNA sequencing analysis. Journal of Psychiatric Research 2022; 147: 39 doi: 10.1016/j.jpsychires.2022.01.003
|
| 38 |
Adriana Farcas, Praise Christi, Felicia Iftene. Cortisol and cytokines in schizophrenia: A scoping review. Comprehensive Psychoneuroendocrinology 2023; 15: 100192 doi: 10.1016/j.cpnec.2023.100192
|
| 39 |
Jingjing Gao, Maomin Qian, Zhengning Wang, Yanling Li, Na Luo, Sangma Xie, Weiyang Shi, Peng Li, Jun Chen, Yunchun Chen, Huaning Wang, Wenming Liu, Zhigang Li, Yongfeng Yang, Hua Guo, Ping Wan, Luxian Lv, Lin Lu, Jun Yan, Yuqing Song, Huiling Wang, Hongxing Zhang, Huawang Wu, Yuping Ning, Yuhui Du, Yuqi Cheng, Jian Xu, Xiufeng Xu, Dai Zhang, Tianzai Jiang. Exploring Schizophrenia Classification Through Multimodal MRI and Deep Graph Neural Networks: Unveiling Brain Region-Specific Weight Discrepancies and Their Association With Cell-Type Specific Transcriptomic Features. Schizophrenia Bulletin 2024; doi: 10.1093/schbul/sbae069
|
| 40 |
Bridget Martinez, Philip V. Peplow. MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment. Neural Regeneration Research 2024; 19(7): 1523 doi: 10.4103/1673-5374.387966
|
| 41 |
Daniela Rodrigues-Amorim, Tania Rivera-Baltanás, Marta López, Carlos Spuch, Jose M. Olivares, Roberto C. Agís-Balboa. Schizophrenia: A review of potential biomarkers. Journal of Psychiatric Research 2017; 93: 37 doi: 10.1016/j.jpsychires.2017.05.009
|
| 42 |
Vjekoslav Peitl, Biserka Getaldić-Švarc, Dalibor Karlović. Platelet Serotonin Concentration Is Associated with Illness Duration in Schizophrenia and Chronological Age in Depression. Psychiatry Investigation 2020; 17(6): 579 doi: 10.30773/pi.2020.0033
|
| 43 |
Jiahui Zhu, Li Zhou, Yuanyuan Zhou, Yunhan Lin, Yumei Cai, Jiayuan Wu, Chuan Shi. Diagnosis of schizophrenia by integrated saccade scores and associations with psychiatric symptoms, and functioning. Medicine 2024; 103(41): e39935 doi: 10.1097/MD.0000000000039935
|
| 44 |
Manabu Makinodan, Keiko Iwata, Daisuke Ikawa, Yasunori Yamashita, Kazuhiko Yamamuro, Michihiro Toritsuka, Sohei Kimoto, Kazuki Okumura, Takahira Yamauchi, Hiroki Yoshino, Masatsugu Tsujii, Toshiro Sugiyama, Kenji Tsuchiya, Norio Mori, Hideo Matsuzaki, Toshifumi Kishimoto. Tumor necrosis factor-alpha expression in peripheral blood mononuclear cells correlates with early childhood social interaction in autism spectrum disorder. Neurochemistry International 2017; 104: 1 doi: 10.1016/j.neuint.2016.12.005
|
| 45 |
Maria N. Grunina, Mariia A. Belinskaia, Alexander S. Zhuravlev, Regina F. Nasyrova, Evgeny M. Krupitsky, Anastasiya E. Taraskina, Anna M. Zabotina. Aberrant alternative splicing of HTR2A exon II in peripheral blood lymphocytes of drug-naïve schizophrenic patients. Heliyon 2020; 6(12): e05809 doi: 10.1016/j.heliyon.2020.e05809
|
| 46 |
Marie Arsalidou, Zachary Yaple, Tomas Jurcik, Vadim Ushakov. Cognitive Brain Signatures of Youth With Early Onset and Relatives With Schizophrenia: Evidence From fMRI Meta-analyses. Schizophrenia Bulletin 2020; 46(4): 857 doi: 10.1093/schbul/sbz130
|
| 47 |
|
| 48 |
Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Yasuko Kitagishi, Satoru Matsuda. D-Amino Acids as a Biomarker in Schizophrenia. Diseases 2022; 10(1): 9 doi: 10.3390/diseases10010009
|
| 49 |
Jobbe Goossens, Manuel Morrens, Violette Coppens. The Potential Use of Peripheral Blood Mononuclear Cells as Biomarkers for Treatment Response and Outcome Prediction in Psychiatry: A Systematic Review. Molecular Diagnosis & Therapy 2021; 25(3): 283 doi: 10.1007/s40291-021-00516-8
|
| 50 |
Jiao Jia, Xiaofei Liu, Lina Ma, Yong Xu, Yan Ren. A Preliminary Analysis of LncRNA Biomarkers for Schizophrenia. Epigenomics 2021; 13(18): 1443 doi: 10.2217/epi-2021-0223
|
| 51 |
Thomas A Pollak, Jonathan P Rogers, Robert G Nagele, Mark Peakman, James M Stone, Anthony S David, Philip McGuire. Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders. Schizophrenia Bulletin 2019; 45(1): 233 doi: 10.1093/schbul/sby021
|
| 52 |
Kiri T. Granger, Anahita Talwar, Jennifer H. Barnett. Latent inhibition and its potential as a biomarker for schizophrenia. Biomarkers in Neuropsychiatry 2020; 3: 100025 doi: 10.1016/j.bionps.2020.100025
|
| 53 |
Diğdem Göverti, Nihan Büyüklüoğlu, Rabia Nazik Yüksel, Hasan Kaya, Çiğdem Yücel, Erol Göka. Decreased serum levels of α‐synuclein in patients with schizophrenia and their unaffected siblings. Early Intervention in Psychiatry 2023; 17(11): 1079 doi: 10.1111/eip.13398
|
| 54 |
Sofia Ramos Ferreira, Diana Moura, Pedro Oliveira, Vítor Santos, Miguel Bajouco, Sofia Morais, Manuel Coroa, Bruno Manadas, Nuno Madeira. Metabolic parameters as possible diagnostic predictors in first‐episode psychosis: An exploratory retrospective cohort study. Early Intervention in Psychiatry 2022; 16(11): 1171 doi: 10.1111/eip.13257
|
| 55 |
Zongchang Li, Ying He, Hongying Han, Yao Zhou, Xiaoqian Ma, Dong Wang, Jun Zhou, Honghong Ren, Liu Yuan, Jinsong Tang, Xiaofen Zong, Maolin Hu, Xiaogang Chen. COMT, 5-HTR2A, and SLC6A4 mRNA Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association With Treatment Outcomes. Frontiers in Psychiatry 2018; 9 doi: 10.3389/fpsyt.2018.00577
|
| 56 |
Diğdem Göverti, Rabia Nazik Yüksel, Hasan Kaya, Nihan Büyüklüoğlu, Çiğdem Yücel, Erol Göka. Serum concentrations of aminoacylase 1 in schizophrenia as a potential biomarker: a case-sibling-control study. Nordic Journal of Psychiatry 2022; 76(5): 380 doi: 10.1080/08039488.2021.1981435
|
| 57 |
Ting Cao, NaNa Li, HuaLin Cai. Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?. Schizophrenia Research 2020; 226: 95 doi: 10.1016/j.schres.2019.03.009
|
| 58 |
Eunkyoung Kim, Zhiling Zhao, John Robertson Rzasa, Matthew Glassman, William E. Bentley, Shuo Chen, Deanna L. Kelly, Gregory F. Payne. Association of acute psychosocial stress with oxidative stress: Evidence from serum analysis. Redox Biology 2021; 47: 102138 doi: 10.1016/j.redox.2021.102138
|
| 59 |
Elizabeth Ruiz-Sánchez, Janet Jiménez-Genchi, Yessica M. Alcántara-Flores, Carlos J. Castañeda-González, Carlos L. Aviña-Cervantes, Petra Yescas, María del Socorro González-Valadez, Nancy Martínez-Rodríguez, Antonio Ríos-Ortiz, Martha González-González, María E. López-Navarro, Patricia Rojas. Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control study. BMC Psychiatry 2021; 21(1) doi: 10.1186/s12888-021-03081-w
|
| 60 |
H Jiang, S Chen, C Li, N Lu, Y Yue, Y Yin, Y Zhang, X Zhi, D Zhang, Y Yuan. The serum protein levels of the tPA–BDNF pathway are implicated in depression and antidepressant treatment. Translational Psychiatry 2017; 7(4): e1079 doi: 10.1038/tp.2017.43
|
| 61 |
Chuanjun Zhuo, Gongying Li, Xiaodong Lin, Deguo Jiang, Yong Xu, Hongjun Tian, Wenqiang Wang, Xueqin Song. Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review. Brain Imaging and Behavior 2021; 15(2): 1115 doi: 10.1007/s11682-020-00284-9
|
| 62 |
Carlos Fernández-Pereira, Maria Aránzazu Penedo, Tania Rivera-Baltanas, Rafael Fernández-Martínez, Saida Ortolano, José Manuel Olivares, Roberto Carlos Agís-Balboa. Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients. International Journal of Molecular Sciences 2022; 23(17): 9591 doi: 10.3390/ijms23179591
|
| 63 |
Jairo Vinícius Pinto, Ives Cavalcante Passos, Fernando Gomes, Ramiro Reckziegel, Flavio Kapczinski, Benson Mwangi, Márcia Kauer-Sant'Anna. Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach. Schizophrenia Research 2017; 188: 182 doi: 10.1016/j.schres.2017.01.018
|
| 64 |
Javier Gilabert-Juan, Guillermo López-Campos, Noelia Sebastiá-Ortega, Sonia Guara-Ciurana, Fulgencio Ruso-Julve, Carlos Prieto, Benedicto Crespo-Facorro, Julio Sanjuán, María Dolores Moltó. Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia. Brain, Behavior, and Immunity 2019; 80: 909 doi: 10.1016/j.bbi.2019.05.015
|
| 65 |
Brian Dean, Elizabeth H.X. Thomas, Kiymet Bozaoglu, Eric J. Tan, Tamsyn E. Van Rheenen, Erica Neill, Philip J. Sumner, Sean P. Carruthers, Elizabeth Scarr, Susan L Rossell, Caroline Gurvich. Evidence that a working memory cognitive phenotype within schizophrenia has a unique underlying biology.. Psychiatry Research 2022; 317: 114873 doi: 10.1016/j.psychres.2022.114873
|
| 66 |
M. N. Grunina, A. M. Zabotina, M. M. Pchelina, R. F. Nasyrova, D. N. Sosin, E. E. Ershov, A. E. Taraskina, E. M. Krupitskiy. Mononuclear Cells of Peripheral Blood in vitro. A Model of Antipsychotic Therapy Personalization. Cell and Tissue Biology 2019; 13(1): 64 doi: 10.1134/S1990519X1901005X
|
| 67 |
Hongyi Yang, Dian Zhu, YanLi Liu, Zhiqi Xu, Zhao Liu, Weibo Zhang, Jun Cai. Employing graph attention networks to decode psycho-metabolic interactions in Schizophrenia. Psychiatry Research 2024; 335: 115841 doi: 10.1016/j.psychres.2024.115841
|
| 68 |
Zhe Lu, Tianyang Wen, Yingtan Wang, Weijing Kan, Guanglei Xun. Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study. BMC Psychiatry 2020; 20(1) doi: 10.1186/s12888-020-02635-8
|
| 69 |
Satyajit Mohite, Fang Yang, Pooja A. Amin, Giovana Zunta-Soares, Gabriela D. Colpo, Laura Stertz, Ajaykumar N. Sharma, Gabriel R. Fries, Consuelo Walss-Bass, Jair C. Soares, Olaoluwa O. Okusaga, Xiang Yang Zhang. Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls. PLOS ONE 2017; 12(3): e0174073 doi: 10.1371/journal.pone.0174073
|
| 70 |
Jennifer Davison, Aoife O'Gorman, Lorraine Brennan, David R. Cotter. A systematic review of metabolite biomarkers of schizophrenia. Schizophrenia Research 2018; 195: 32 doi: 10.1016/j.schres.2017.09.021
|
| 71 |
Fei Ye, Qiongqiong Zhan, Wenhuan Xiao, Weiwei Sha, Xiaobin Zhang. Altered serum levels of glial cell line‐derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia. International Journal of Methods in Psychiatric Research 2018; 27(4) doi: 10.1002/mpr.1727
|
| 72 |
Hyerim Kim, Xudong Wang, Peng Jin. Developing DNA methylation-based diagnostic biomarkers. Journal of Genetics and Genomics 2018; 45(2): 87 doi: 10.1016/j.jgg.2018.02.003
|
| 73 |
Chuanjun Zhuo, Yudong Yao, Yong Xu, Chuanxin Liu, Min Chen, Feng Ji, Jie Li, Hongjun Tian, Deguo Jiang, Chongguang Lin, Ce Chen. Schizophrenia and gut-flora related epigenetic factors. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019; 90: 49 doi: 10.1016/j.pnpbp.2018.11.005
|
| 74 |
Ladislav Hosák. Biomarkers of schizophrenia - a brief review and the recent knowledge. Psychiatrie pro praxi 2016; 17(2): 44 doi: 10.36290/psy.2016.012
|
| 75 |
M. N. Grunina, A. M. Zabotina, A. S. Zhuravlev, M. M. Pchelina, E. V. Volkova, R. F. Nasyrova, A. E. Taraskina, E. M. Krupitsky. DOPAMINE RECEPTOR D2 (DRD2) IN PERIPHERAL BLOOD LYMPHOCYTES AS BIOMARKER OF RESPONSE TO ANTIPSYCHOTIC MEDICATION. The Scientific Notes of the Pavlov University 2020; 27(1): 45 doi: 10.24884/1607-4181-2020-27-1-45-56
|
| 76 |
Yuanhao Yang, Yuan Zhou, Dale R. Nyholt, Chloe X. Yap, Rudolph K. Tannenberg, Ying Wang, Yang Wu, Zhihong Zhu, Bruce V. Taylor, Jacob Gratten. The shared genetic landscape of blood cell traits and risk of neurological and psychiatric disorders. Cell Genomics 2023; 3(2): 100249 doi: 10.1016/j.xgen.2022.100249
|
| 77 |
Brian Dean, Geor Bakker, Hiroki R. Ueda, Andrew B. Tobin, Alastair Brown, Richard A. A. Kanaan. A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia. Frontiers in Cellular Neuroscience 2023; 17 doi: 10.3389/fncel.2023.1124333
|
| 78 |
Berko Milleit, Jana Hesse, Kerstin Langbein, Kristin Rödiger, Christine Milleit, Ute C. Meier, Peter Elsner, Uta-Christina Hipler, Stefan Smesny. Pronounced immunological abnormalities in unmedicated first episode as compared to chronic schizophrenia patients. Neurology, Psychiatry and Brain Research 2019; 34: 58 doi: 10.1016/j.npbr.2019.10.002
|
| 79 |
Benjamín Rodríguez, João Victor Nani, Priscila G.C. Almeida, Elisa Brietzke, Richard S. Lee, Mirian A.F. Hayashi. Neuropeptides and oligopeptidases in schizophrenia. Neuroscience & Biobehavioral Reviews 2020; 108: 679 doi: 10.1016/j.neubiorev.2019.11.024
|
| 80 |
Davin Lee, Jinsoo Seo, Hae chan Jeong, Hyosang Lee, Sung Bae Lee. The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons. Frontiers in Molecular Neuroscience 2021; 14 doi: 10.3389/fnmol.2021.756613
|
| 81 |
Andrea Schmitt, Daniel Martins-de-Souza, Schahram Akbarian, Juliana S. Cassoli, Hannelore Ehrenreich, Andre Fischer, Alfred Fonteh, Wagner F. Gattaz, Michael Gawlik, Manfred Gerlach, Edna Grünblatt, Tobias Halene, Alkomiet Hasan, Kenij Hashimoto, Yong-Ku Kim, Sophie-Kathrin Kirchner, Johannes Kornhuber, Theo F.J. Kraus, Berend Malchow, Juliana M. Nascimento, Moritz Rossner, Markus Schwarz, Johann Steiner, Leda Talib, Florence Thibaut, Peter Riederer, Peter Falkai. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. The World Journal of Biological Psychiatry 2017; 18(5): 330 doi: 10.1080/15622975.2016.1224929
|
| 82 |
Bolun Cheng, Yunfeng Bai, Li Liu, Peilin Meng, Shiqiang Cheng, Xuena Yang, Chuyu Pan, Wenming Wei, Huan Liu, Yumeng Jia, Yan Wen, Feng Zhang. Mendelian randomization study of the relationship between blood and urine biomarkers and schizophrenia in the UK Biobank cohort. Communications Medicine 2024; 4(1) doi: 10.1038/s43856-024-00467-1
|
| 83 |
Daniela Rodrigues-Amorim, Tania Rivera-Baltanás, María del Carmen Vallejo-Curto, Cynthia Rodriguez-Jamardo, Elena de las Heras, Carolina Barreiro-Villar, María Blanco-Formoso, Patricia Fernández-Palleiro, María Álvarez-Ariza, Marta López, Alejandro García-Caballero, José Manuel Olivares, Carlos Spuch. Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways. Frontiers in Psychiatry 2019; 10 doi: 10.3389/fpsyt.2019.00885
|
| 84 |
Kamil Jonak, Arkadiusz Syta, Hanna Karakuła-Juchnowicz, Paweł Krukow. The Clinical Application of EEG-Signals Recurrence Analysis as a Measure of Functional Connectivity: Comparative Case Study of Patients with Various Neuropsychiatric Disorders. Brain Sciences 2020; 10(6): 380 doi: 10.3390/brainsci10060380
|
| 85 |
Matea Perkovic, Gordana Erjavec, Dubravka Strac, Suzana Uzun, Oliver Kozumplik, Nela Pivac. Theranostic Biomarkers for Schizophrenia. International Journal of Molecular Sciences 2017; 18(4): 733 doi: 10.3390/ijms18040733
|
| 86 |
Kärt Kriisa, Liisa Leppik, Roman Balõtšev, Aigar Ottas, Ursel Soomets, Kati Koido, Vallo Volke, Jürgen Innos, Liina Haring, Eero Vasar, Mihkel Zilmer. Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment. Journal of Proteome Research 2017; 16(10): 3558 doi: 10.1021/acs.jproteome.7b00279
|
| 87 |
Weichen Song, Lihua Xu, Tianhong Zhang, Weidi Wang, Yingmei Fu, Qingqing Xu, Ruixue Yuan, Ailing Ning, Jijun Wang, Guan Ning Lin, Shunying Yu. Peripheral transcriptome of clinical high‐risk psychosis reflects symptom alteration and helps prognosis prediction. Psychiatry and Clinical Neurosciences 2022; 76(6): 268 doi: 10.1111/pcn.13346
|
| 88 |
Hamid Fallah, Iman Azari, Seyedeh Morvarid Neishabouri, Vahid Kholghi Oskooei, Mohammad Taheri, Soudeh Ghafouri-Fard. Sex-specific up-regulation of lncRNAs in peripheral blood of patients with schizophrenia. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49265-z
|
| 89 |
Mitsuyuki Matsumoto, Noah M. Walton, Hiroshi Yamada, Yuji Kondo, Gerard J. Marek, Katsunori Tajinda. The impact of genetics on future drug discovery in schizophrenia. Expert Opinion on Drug Discovery 2017; 12(7): 673 doi: 10.1080/17460441.2017.1324419
|
| 90 |
Jingjing Lin, Xiaohui Hou, Yaxi Liu, Yixian Cai, Jiyang Pan, Jiwu Liao. Elevated peripheral glutamate and upregulated expression of NMDA receptor NR1 subunit in insomnia disorder. Frontiers in Psychiatry 2024; 15 doi: 10.3389/fpsyt.2024.1436024
|
| 91 |
Suzhen Chen, Haitang Jiang, Yang Liu, Zhenhua Hou, Yingying Yue, Yuqun Zhang, Fuying Zhao, Zhi Xu, Yinghui Li, Xiaodong Mou, Lei Li, Tianyu Wang, Jingjing Zhao, Chongyang Han, Yuxiu Sui, Ming Wang, Zhong Yang, Yan Lu, Yifeng Zhu, Jianhua Li, Xinhua Shen, Fei Sun, Qingsong Chen, Huanxin Chen, Yonggui Yuan. Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06832-6
|
| 92 |
Else Eising, Nadine Pelzer, Lisanne S. Vijfhuizen, Boukje de Vries, Michel D. Ferrari, Peter A. C. ‘t Hoen, Gisela M. Terwindt, Arn M. J. M. van den Maagdenberg. Identifying a gene expression signature of cluster headache in blood. Scientific Reports 2017; 7(1) doi: 10.1038/srep40218
|
| 93 |
Dag K. Solberg, Helge Refsum, Ole A. Andreassen, Håvard Bentsen. A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia. Acta Neuropsychiatrica 2019; 31(04): 202 doi: 10.1017/neu.2019.14
|
| 94 |
Eunkyoung Kim, Zoe Keskey, Mijeong Kang, Christopher Kitchen, William E. Bentley, Shuo Chen, Deanna L. Kelly, Gregory F. Payne. Validation of oxidative stress assay for schizophrenia. Schizophrenia Research 2019; 212: 126 doi: 10.1016/j.schres.2019.07.057
|
| 95 |
Konstantinos N. Fountoulakis, Panagiotis Panagiotidis, Thomas Tegos, Vasileios Kimiskidis, Ioannis Nimatoudis. Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 2022; 272(6): 1087 doi: 10.1007/s00406-021-01357-6
|
| 96 |
A. E. Taraskina, R. F. Nasyrova, A. M. Zabotina, D. N. Sosin, К. А. Sosina, E. E. Ershov, M. N. Grunina, E. M. Krupitsky. Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines. BMC Psychiatry 2017; 17(1) doi: 10.1186/s12888-017-1562-1
|
| 97 |
Sanghyeon Kim, Yousang Jo, Maree J. Webster, Doheon Lee. Shared co-expression networks in frontal cortex of the normal aged brain and schizophrenia. Schizophrenia Research 2019; 204: 253 doi: 10.1016/j.schres.2018.09.010
|
| 98 |
Chao Li, Zhenchun Shi, Jiacui Ji, Gengyun Niu, Zengxun Liu. Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study. Neuropsychiatric Disease and Treatment 2021; : 2575 doi: 10.2147/NDT.S322005
|
| 99 |
Р.Т. КЕНЖЕБЕКОВА, З.С. КАЧИЕВА, А.А. АБЕТОВА, Н.И. РАСПОПОВА, Ж.Н. АХМЕТОВА, А. ТОЛЕГЕНКЫЗЫ, Г.С. БИСМИЛДИНА, С.К. САЛИМБЕКОВА, Ж.Б. ТИЛЕУЛЕС, Д.Б. ТУРАРОВА, Н.А. РАХИТОВА, Т.М. САЛИЕВ. ШИЗОФРЕНИЯНЫҢ ПАТОФИЗИОЛОГИЯСЫ ЖӘНЕ МОЛЕКУЛАЛЫҚ ГЕНЕТИКАЛЫҚ ТРИГЕРЛЕРІ. Vestnik 2022; (4(63)): 169 doi: 10.53065/s5465-1799-2579-d
|
| 100 |
Yuriy M. Kositsyn, Murilo S. de Abreu, Tatiana O. Kolesnikova, Alexey A. Lagunin, Vladimir V. Poroikov, Hasmik S. Harutyunyan, Konstantin B. Yenkoyan, Allan V. Kalueff. Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies. International Journal of Molecular Sciences 2023; 24(11): 9482 doi: 10.3390/ijms24119482
|
| 101 |
Phatcharee Chukaew, Nutthaya Bunmak, Natchaphon Auampradit, Apinya Siripaiboonkij, Witchuda Saengsawang, Woraphat Ratta‐apha. Correlation of BDNF, VEGF, TNF‐α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients. Neuropsychopharmacology Reports 2022; 42(3): 281 doi: 10.1002/npr2.12261
|
| 102 |
Anastasia Levchenko, Timur Nurgaliev, Alexander Kanapin, Anastasia Samsonova, Raul R. Gainetdinov. Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders. Heliyon 2020; 6(5): e03990 doi: 10.1016/j.heliyon.2020.e03990
|
| 103 |
Matej Ľupták, Danica Michaličková, Zdeněk Fišar, Eva Kitzlerová, Jana Hroudová. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets. World Journal of Psychiatry 2021; 11(7): 277-296 doi: 10.5498/wjp.v11.i7.277
|
| 104 |
Elior Rahmani, Regev Schweiger, Liat Shenhav, Theodora Wingert, Ira Hofer, Eilon Gabel, Eleazar Eskin, Eran Halperin. BayesCCE: a Bayesian framework for estimating cell-type composition from DNA methylation without the need for methylation reference. Genome Biology 2018; 19(1) doi: 10.1186/s13059-018-1513-2
|
| 105 |
Chen-Xi Xu, Wei Huang, Xiao-Jie Shi, Yang Du, Jia-Quan Liang, Xuan Fang, He-Yuan Chen, Yong Cheng. Dysregulation of Serum Exosomal Lipid Metabolism in Schizophrenia: A Biomarker Perspective. Molecular Neurobiology 2024; doi: 10.1007/s12035-024-04477-x
|
| 106 |
Dariusz Juchnowicz, Michał Dzikowski, Joanna Rog, Napoleon Waszkiewicz, Kaja Hanna Karakuła, Anna Zalewska, Mateusz Maciejczyk, Hanna Karakula-Juchnowicz. Pro/Antioxidant State as a Potential Biomarker of Schizophrenia. Journal of Clinical Medicine 2021; 10(18): 4156 doi: 10.3390/jcm10184156
|
| 107 |
Daniel Schöttle, Klaus Wiedemann, Christoph U. Correll, Wolfgang Janetzky, Michael Friede, Holger Jahn, Andreas Brieden. Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly. Schizophrenia Research 2023; 260: 183 doi: 10.1016/j.schres.2023.08.026
|
| 108 |
Yasunari Yamaguchi, Kazuya Okamura, Kazuhiko Yamamuro, Kazuki Okumura, Takashi Komori, Michihiro Toritsuka, Ryohei Takada, Yosuke Nishihata, Daisuke Ikawa, Takahira Yamauchi, Manabu Makinodan, Hiroki Yoshino, Yasuhiko Saito, Hideo Matsuzaki, Toshifumi Kishimoto, Sohei Kimoto. NARP-related alterations in the excitatory and inhibitory circuitry of socially isolated mice: developmental insights and implications for autism spectrum disorder. Frontiers in Psychiatry 2024; 15 doi: 10.3389/fpsyt.2024.1403476
|
| 109 |
Sha Liu, Fuquan Zhang, Xijin Wang, Yin Yao Shugart, Yingying Zhao, Xinrong Li, Zhifen Liu, Ning Sun, Chunxia Yang, Kerang Zhang, Weihua Yue, Xin Yu, Yong Xu. Diagnostic value of blood-derived microRNAs for schizophrenia: results of a meta-analysis and validation. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-15751-5
|
| 110 |
Lawrence W. Rook. Biomarkers of mental illness and the human hand: A systematic review. The European Journal of Psychiatry 2022; 36(2): 77 doi: 10.1016/j.ejpsy.2022.01.007
|
| 111 |
Marina Sergeevna Konkova, Elizaveta Sergeevna Ershova, Ekaterina Alekseevna Savinova, Elena Mikhailovna Malinovskaya, Galina Vasilievna Shmarina, Andrey Vladimirovich Martynov, Roman Vladimirovich Veiko, Nataly Vyacheslavovna Zakharova, Pavel Umriukhin, Georgy Petrovich Kostyuk, Vera Leonidovna Izhevskaya, Sergey Ivanovich Kutsev, Natalia Nikolaevna Veiko, Svetlana Victorovna Kostyuk. 1Q12 Loci Movement in the Interphase Nucleus Under the Action of ROS Is an Important Component of the Mechanism That Determines Copy Number Variation of Satellite III (1q12) in Health and Schizophrenia. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00386
|
| 112 |
I. V. Chestkov, E. M. Jestkova, E. S. Ershova, V. G. Golimbet, T. V. Lezheiko, N. Yu Kolesina, O. A. Dolgikh, V. L. Izhevskaya, G. P. Kostyuk, S. I. Kutsev, N. N. Veiko, S. V. Kostyuk, Tanea T. Reed. ROS‐Induced DNA Damage Associates with Abundance of Mitochondrial DNA in White Blood Cells of the Untreated Schizophrenic Patients. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/8587475
|
| 113 |
Ye Lv, Lin Wen, Wen-Juan Hu, Chong Deng, Hui-Wen Ren, Ya-Nan Bao, Bo-Wei Su, Ping Gao, Zi-Yue Man, Yi-Yang Luo, Cheng-Jie Li, Zhi-Xin Xiang, Bing Wang, Zhi-Lin Luan. Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches to insights of susceptibility genes. Metabolic Brain Disease 2023; 39(1): 147 doi: 10.1007/s11011-023-01271-x
|